[1]
B. Melnikas and R. Smaliukienė, “Consumer vulnerability in pharmaceutical market: Case of Baltic countries”, JBEM, vol. 8, no. 1, pp. 51–62, Mar. 2007, doi: 10.3846/16111699.2007.9636152.